Allurion expects FY25 net sales of 15M
Seeking Alpha News (Mon, 12-Jan 9:48 AM ET)
Allurion Announces Preliminary Fourth Quarter and Full-Year 2025 Results
Business Wire (Mon, 12-Jan 8:30 AM ET)
Business Wire (Tue, 25-Nov 9:25 AM ET)
Business Wire (Thu, 20-Nov 9:00 AM ET)
Business Wire (Tue, 18-Nov 9:00 AM ET)
Allurion Reports Third Quarter 2025 Financial Results and Provides Business Update
Business Wire (Wed, 12-Nov 8:00 AM ET)
Business Wire (Tue, 11-Nov 8:45 AM ET)
Allurion to Report Third Quarter 2025 Financial Results on November 12, 2025
Business Wire (Thu, 6-Nov 4:05 PM ET)
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
Allurion Technologies trades on the NYSE stock market under the symbol ALUR.
As of January 16, 2026, ALUR stock price declined to $1.85 with 30,075 million shares trading.
ALUR has a beta of 2.39, meaning it tends to be more sensitive to market movements. ALUR has a correlation of 0.05 to the broad based SPY ETF.
ALUR has a market cap of $22.72 million. This is considered a Sub-Micro Cap stock.
Last quarter Allurion Technologies reported $3 million in Revenue and -$1.18 earnings per share. This beat revenue expectation by $608,000 and exceeded earnings estimates by $.56.
The top ETF exchange traded funds that ALUR belongs to (by Net Assets): VXF.
ALUR has underperformed the market in the last year with a return of -40.7%, while the SPY ETF gained +18.1%. In the last 3 month period, ALUR fell short of the market, returning -8.9%, while SPY returned +5.0%. However, in the most recent 2 weeks ALUR has outperformed the stock market by returning +27.6%, while SPY returned +1.2%.
ALUR support price is $1.74 and resistance is $2.04 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALUR shares will trade within this expected range on the day.
